


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
GMAB
Genmab A/S ADS
$30.42
Strengths

Upgraded on attractively valued
Chart
$30.6 (-0.59%)
$24.65 (+23.41%)
$20.73 (+46.74%)
$21.5 (+41.49%)
GMAB has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

GMAB overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Earnings increase YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future
![]()
GMAB Analysts opinion is negative but has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
GMAB Street Sentiment is extremely bullish and have negative views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is GMAB current stock price?
What are GMAB stock strengths?
What is GMAB Risk Level?
What is GMAB market cap and volume?
What is GMAB current Stock IQ?
Should I buy GMAB stock right now?
Is GMAB a Strong Buy right now?
What does a 'Strong Buy' rating mean for GMAB?
What does a 'Strong Sell' rating mean for GMAB?
What factors influence GMAB's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
GMAB
Genmab A/S ADS
Current Price
$30.42
Stock Insights
Strengths

Upgraded on attractively valued

Chart
$30.6 (-0.59%)
$24.65 (+23.41%)
$20.73 (+46.74%)
$21.5 (+41.49%)
GMAB Analysts Opinion
GMAB Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Earnings increase YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future
![]()
GMAB Analysts opinion is negative but has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
GMAB Street Sentiment is extremely bullish and have negative views on the near-term outlook
GMAB has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels.
GMAB Latest Analysis
Genmab Nine-Mont Profit Rises . (RTTNews) - Genmab A/S (GMAB) Thursday reported net profit of 932 million euros or 14.90 euros per share compared to 581 million euros or 8.99 euros per share last year.
Thu Nov 6, 2025
Genmab to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference in London. Media ReleaseCOPENHAGEN Denmark. November 5 2025Genmab A/S (Nasdaq: GMAB) announced today that its Chief Executive Officer Jan Van de Winkel and Chief Financial Officer Anthony Pagano will participate in a fireside chat at the Jefferies Global Healthcare Conference in London at 12:00 PM GMT (7:00 AM EST) on November 19 2025. A webcast of the fireside chat will be available on Genmabs website at .
Wed Nov 5, 2025
H.C. Wainwright Maintains a Buy Rating on Genmab A/S (GMAB). Genmab A/S (NASDAQ:GMAB) is one of the most profitable biotech stocks to buy. H.C. Wainwright analyst Ram Selvaraju maintained a Buy rating on Genmab A/S (NASDAQ:GMAB) on October 21 with a $40 price target. The analyst cited the promising clinical developments in the companys portfolio stating that the recent presentation at the ESMO meeting showed the [….]
Tue Oct 28, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
GMAB Stock trends
GMAB Stock performance
GMAB Stock analysis
GMAB investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.